[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"middle-meningeal-artery-embolization\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:middle-meningeal-artery-embolization":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100651231","comparative-study-of-embolic-agents-in-patients-with-subdural-hemorrhage-undergoing-middle-meningeal-artery-mma-embolization-100651231",false,"NCT07757113","Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization","Inclusion Criteria:\n\n* Adult patients (≥ 18 years)\n* Undergoing Middle Meningeal Artery Embolization (MMAE) for chronic subdural hematoma (cSDH)\n* Able to provide informed consent or have a legally authorized representative (LAR) do so\n\nExclusion Criteria:\n\n* Ineligible for MMAE procedure, as deemed by the treating physician, for any indication (e.g. pregnancy)\n* Non-chronic subdural hematoma (cSDH) indications for Middle Meningeal Artery Embolization (MMAE), including acute subdural hematoma with symptom onset \\\u003C 72 hours or mixed acute\u002Fchronic without predominant chronic features\n* Pregnancy or breastfeeding\n* Known severe allergy or contraindication to embolic materials (e.g. particles, liquids like Onyx\u002Fn-BCA, or coils)\n* Inability to undergo angiography (e.g. severe renal impairment contraindicating contrast)\n* Inability or unwillingness to complete follow-up visits at 30 and 90 days","ALL","18 Years",{"count":18,"type":19},30,"ESTIMATED","INTERVENTIONAL",[22],"NA","Single site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.",[25,26,27],"Chronic Subdural Hematoma","Stroke","Middle Meningeal Artery Embolization","NOT_YET_RECRUITING","2026-08-05",{"date":31,"type":32},"2026-08-11","ACTUAL",{"date":34,"type":19},"2026-09",{"date":36,"type":19},"2028-03",{"name":38,"class":39},"Sanford Health","OTHER"]